1. Home
  2. TRX vs MYGN Comparison

TRX vs MYGN Comparison

Compare TRX & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

HOLD

Current Price

$1.36

Market Cap

470.0M

Sector

N/A

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.68

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRX
MYGN
Founded
1990
1991
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.0M
481.6M
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
TRX
MYGN
Price
$1.36
$4.68
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$1.70
$7.64
AVG Volume (30 Days)
4.5M
1.8M
Earning Date
04-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$73.52
$7.19
Revenue Next Year
$109.74
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.33
52 Week Low
$0.27
$3.76
52 Week High
$2.80
$9.48

Technical Indicators

Market Signals
Indicator
TRX
MYGN
Relative Strength Index (RSI) 39.40 44.59
Support Level $0.32 $4.24
Resistance Level $1.95 $5.69
Average True Range (ATR) 0.12 0.32
MACD -0.06 0.00
Stochastic Oscillator 15.54 32.04

Price Performance

Historical Comparison
TRX
MYGN

About TRX TRX Gold Corporation

TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: